Simponi approved for ulcerative colitis
(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.
Medications
May 15, 2013 |
not rated yet |
0
Targeting inflammation to treat depression
Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of ...
Psychology & Psychiatry
Sep 03, 2012 |
4.9 / 5 (18) |
3
|
MicroRNA derails protein that blocks insulin production
(Medical Xpress)—Work by Michigan Technological University biologist Xiaoqing Tang is yielding new insights into how a tiny snippet of genetic material can promote healthy insulin production in mice.
Medical research
Sep 20, 2012 |
5 / 5 (2) |
0
|
Immune response linked to key enzyme
(Medical Xpress)—A previously unknown function of a family of enzymes familiar to biologists may contribute to scientists' understanding of signaling molecules involved in the body's immune response and ...
Immunology
Apr 12, 2013 |
5 / 5 (3) |
0
|
Researchers identify new target for rheumatoid arthritis
Researchers at Hospital for Special Surgery have identified a potential new target for drugs to treat patients with rheumatoid arthritis (RA), a protein known as IRHOM2. The finding could provide an effective ...
Arthritis & Rheumatism
Jan 25, 2013 |
5 / 5 (5) |
0
|
Some harmful effects of light at night can be reversed: study
Chronic exposure to dim light at night can lead to depressive symptoms in rodents -- but these negative effects can be reversed simply by returning to a standard light-dark cycle, a new study suggests.
Psychology & Psychiatry
Jul 24, 2012 |
5 / 5 (5) |
0
|
Cell-destroyer that fights and promotes TB reveals what's behind its split identity
Tumor necrosis factor—normally an infection-fighting substance produced by the body—can actually heighten susceptibility to tuberculosis if its levels are too high. University of Washington TB researchers ...
Diseases, Conditions, Syndromes
Apr 11, 2013 |
5 / 5 (1) |
0
|
Tuberculosis bacterium's outer cell wall disarms the body's defense to remain infectious
The bacterium that causes tuberculosis has a unique molecule on its outer cell surface that blocks a key part of the body's defense. New research suggests this represents a novel mechanism in the microbe's evolving efforts ...
Diseases, Conditions, Syndromes
Oct 03, 2011 |
5 / 5 (3) |
0
|
Recipient's immune system governs stem cell regeneration
A new study in Nature Medicine describes how different types of immune system T-cells alternately discourage and encourage stem cells to regrow bone and tissue, bringing into sharp focus the importance of the transplant recipient's ...
Medical research
Nov 20, 2011 |
5 / 5 (2) |
0
|
Use of biologic therapies for inflammatory diseases does not appear to increase risk of shingles
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic ...
Inflammatory disorders
Apr 19, 2013 |
not rated yet |
0
Chronic exposure to dim light may raise depression risk
Two years ago, Randy Nelson, Ph.D., chair of neuroscience at Ohio State University, doctoral student Tracy Bedrosian, and colleagues reported that dim-light exposure at night was capable of triggering depressive-like ...
Psychology & Psychiatry
Sep 24, 2012 |
5 / 5 (2) |
0
Etanercept seems beneficial in partial spinal cord injury
(HealthDay)—Treatment of rabbits with a partial spinal cord injury (SCI) with the intramuscularly-administered tumor necrosis factor-α (TNF-α) inhibitor etanercept is associated with improved clinical ...
Diseases, Conditions, Syndromes
Jan 11, 2013 |
1 / 5 (1) |
0
Use of certain therapies for inflammatory diseases does not appear to increase risk of shingles
Although patients with rheumatoid arthritis (RA) have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that ...
Inflammatory disorders
Mar 05, 2013 |
not rated yet |
0
Study examines risk of heart attack associated with various psoriasis treatments
Use of tumor necrosis factor (TNF) inhibitors for treatment of psoriasis is associated with a significantly reduced risk for heart attack (myocardial infarction) compared to other forms of treatment, according to a report ...
Diseases, Conditions, Syndromes
Aug 20, 2012 |
not rated yet |
0
|
Biologic therapy for rheumatoid arthritis not significantly linked with increased malignancy risk
Although there are concerns regarding the potential development of malignancies in patients with rheumatoid arthritis who are receiving treatment with biologic response modifiers (BRMs), pooled results from more than 60 randomized ...
Arthritis & Rheumatism
Sep 04, 2012 |
not rated yet |
0
|
